SEC Company Filings


Filing DateForm (Link to docs.)DescriptionDownload
21-01-13S-4Registration of securities, business combinationsPDF
21-01-11425Prospectuses and communications, business combinationsPDF
21-01-05425Prospectuses and communications, business combinationsPDF
20-12-158-KCurrent report, items 1.01, 8.01, and 9.01PDF
20-12-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialPDF
20-11-1610-QQuarterly report [Sections 13 or 15(d)]PDF
20-10-208-KCurrent report, item 5.02PDF
20-8-1410-QQuarterly report [Sections 13 or 15(d)]PDF
20-7-158-KCurrent report, item 5.02PDF
20-7-98-KCurrent report, items 5.02 and 8.01PDF
20-5-218-KCurrent report, item 5.02PDF
20-5-710-QQuarterly report [Sections 13 or 15(d)]PDF
20-5-68-KCurrent report, items 5.02, 7.01, and 9.01PDF
20-4-248-KCurrent report, item 5.07PDF
20-4-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialPDF
20-4-158-KCurrent report, item 3.01PDF
20-3-30Pre 14AOther preliminary proxy statementsPDF
20-3-17S-8Securities to be offered to employees in employee benefit plansPDF
20-3-1710-KAnnual report [Section 13 and 15(d), not S-K Item 405]PDF
20-3-168-KCurrent report, item 8.01PDF
20-2-108-KCurrent report, items 5.02 and 8.01PDF
20-2-48-KCurrent report, items 2.05, 7.01, and 9.01PDF
20-1-318-KCurrent report, item 8.01PDF
20-1-108-KCurrent report, item 8.01PDF
20-1-28-KCurrent report, items 5.02 and 8.01PDF
19-11-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-11-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-9-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-8-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-8-66-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-7-22S-8Securities to be offered to employees in employee benefit plansPDF
19-7-86-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-6-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-5-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-5-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-4-2420-F/A[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]PDF
19-3-2520-KAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]PDF
19-3-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-3-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-2-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-2-13424B4Prospectus [Rule 424(b)(4)]PDF
19-2-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
19-2-11F-1/A[Amend] Registration statement for certain foreign private issuersPDF
19-2-88-A12BRegistration of securities [Section 12(b)]PDF
19-2-8F-1/A[Amend] Registration statement for certain foreign private issuersPDF
19-2-7F-1/A[Amend] Registration statement for certain foreign private issuersPDF
19-1-30F-1/A[Amend] Registration statement for certain foreign private issuersPDF
19-1-7F-1Registration statement for certain foreign private issuers PDF

Anchiano Therapeutics Ltd. CIK#: 0001534248